Drug Discovery & Pharmaceuticals

RSS

New ECL-based mechanism enables development of increasingly efficient serological tests

A research group led by the University of Bologna identified a new mechanism that allows to obtain serological tests that are quicker, more cost-effective and more reliable than those currently in use.

5 Jun 2020

Using supercomputers to knock out drug side effects

Psychedelic drugs could be effective in treating psychiatric disorders such as depression and post-traumatic stress disorder, but medical use of these drugs is limited by the hallucinations they cause.

4 Jun 2020

Two marine molecules show potential to treat Alzheimer's disease

An interdisciplinary research study of the University of Barcelona identified two potential candidates to treat Alzheimer's disease. These are two marine molecules, meridianine and lignarenone B, able to alter the activity of GSK3B activity, a protein associated with several neurodegenerative diseases.

28 May 2020

Hydrocarbon bonds may help synthesize large range of novel organic molecules

The most common chemical bond in the living world -- that between carbon and hydrogen -- has long resisted attempts by chemists to crack it open, thwarting efforts to add new bells and whistles to old carbon-based molecules.

22 May 2020

New metal-free methodology for fluorination of aliphatic hydrocarbon bonds

Researchers from the Muñiz group have published a paper in Angewandte Chemie - International Edition presenting a new metal-free methodology for the photo-catalyzed nucleophilic fluorination of aliphatic hydrocarbon bonds.

21 May 2020

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, and Celonic Group, a premium biopharmaceutical CDMO specialized in the development and production of Advance Therapy Medicinal Products (ATMPs) and mammalian cell line-expressed biotherapeutics, today announced a collaboration to produce the novel human recombinant protein AT-100 (rhSP-D) as a therapeutic candidate against COVID-19.

21 May 2020

Cell-culture based in vitro test systems for antitumor drug screening

As we know, a malignant tumor is a complex system of mutated cells which constantly interacts with and involves healthy cells in the body.

21 May 2020

New study may eliminate dangerous side effects of drugs used for treating various conditions

Psychedelics such as LSD and magic mushrooms have proven highly effective in treating depression and post-traumatic stress disorders, but medical use of these drugs is limited by the hallucinations they cause.

20 May 2020

New technique produces pure therapeutic drugs without the associated side effects

Scientists from Hong Kong Baptist University (HKBU) have developed a novel technique that can produce pure therapeutic drugs without the associated side effects.

19 May 2020

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern LP. By acquiring this entity, which focuses on therapeutic antibodies targeting the tumor microenvironment, Boehringer Ingelheim is now positioned at the forefront of the stromal biology space - an emerging area in cancer immunology.

From Boehringer Ingelheim International GmbH 18 May 2020

Boehringer Ingelheim partners with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

Boehringer Ingelheim and CDR-Life today announced they have entered into a collaboration and licensing agreement to research and develop antibody fragment-based therapeutics for geographic atrophy (GA).

From Boehringer Ingelheim International GmbH 15 May 2020

New drugs developed for treating polycystic hepatorenal diseases

Polycystic hepatorenal diseases are hereditary, genetic disorders characterized by the progressive development of multiple symptomatic cysts in the kidneys and/or liver which may cause alterations in the function of these organs and/or complications associated with their growth.

11 May 2020

Therapeutic peptides that can be taken orally

Peptides are short chains of amino acids that occur in our body, in plants or bacteria to control diverse functions.

11 May 2020

New breakthrough in chemistry could accelerate drug development

Scientists have successfully developed a new technique to reliably grow crystals of organic soluble molecules from nanoscale droplets, unlocking the potential of accelerated new drug development.

8 May 2020

Arrayjet develops COVID-19 antibody screening technology to facilitate vaccine development

Arrayjet Limited, the Scottish-based bio-printing technology specialist for the life sciences industry, has re-purposed its in-house antibody screening technology to create a population-scale diagnostic program that will help scientists better understand the behavior of the Covid-19 virus and further the rapidity of a global vaccination program.

7 May 2020

Human to Labskin Skin Models for Dermatology Research

A Human Skin Equivalent (HSE) skin model used for dermatology research, made from the same primary human cells but grown to a defined specification in a laboratory and not as complex as Human skin, lacking hair follicles and immune cells.

6 May 2020

GeoVax and Sino Biological establish exclusive supply agreement for research grade bioreagents related to SARS-CoV-2 (COVID-19) vaccine development

GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced today that Beijing- and Philadelphia-based Sino Biological, Inc. will be its exclusive supplier of SARS-CoV-2 (COVID-19) bioreagent research products.

From Sino Biological Inc. 6 May 2020

Drug Discovery & Pharmaceuticals

New ECL-based mechanism enables development of increasingly efficient serological tests

Using supercomputers to knock out drug side effects

Two marine molecules show potential to treat Alzheimer's disease

Hydrocarbon bonds may help synthesize large range of novel organic molecules

New metal-free methodology for fluorination of aliphatic hydrocarbon bonds

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Cell-culture based in vitro test systems for antitumor drug screening

New study may eliminate dangerous side effects of drugs used for treating various conditions

New technique produces pure therapeutic drugs without the associated side effects

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Boehringer Ingelheim partners with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

New drugs developed for treating polycystic hepatorenal diseases

Therapeutic peptides that can be taken orally

New breakthrough in chemistry could accelerate drug development

Arrayjet develops COVID-19 antibody screening technology to facilitate vaccine development

Human to Labskin Skin Models for Dermatology Research

GeoVax and Sino Biological establish exclusive supply agreement for research grade bioreagents related to SARS-CoV-2 (COVID-19) vaccine development

Study reports cryo-EM structure of Remdesivir-bound RNA replicase complex from SARS-CoV-2

Using Multiplex Assays to Discover Biomarkers for Parkinson’s Disease

UK-based biotechnology firm discovers potential treatments for Covid-19

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest Life Science News